These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Complications of use of intrauterine devices among HIV-1-infected women. Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743 [TBL] [Abstract][Full Text] [Related]
15. Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach. Sufrin CB; Averbach SH Clin Obstet Gynecol; 2014 Dec; 57(4):682-93. PubMed ID: 25222531 [TBL] [Abstract][Full Text] [Related]
16. Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial. Kakaire O; Byamugisha JK; Tumwesigye NM; Gemzell-Danielsson K Hum Reprod; 2015 Jul; 30(7):1573-9. PubMed ID: 25979373 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic prophylaxis in gynaecologic procedures. Van Eyk N; van Schalkwyk J; J Obstet Gynaecol Can; 2012 Apr; 34(4):382-391. PubMed ID: 22472341 [TBL] [Abstract][Full Text] [Related]
18. Pratiques optimales en vue de minimiser le risque d'infection au moment de l'insertion d'un dispositif intra-utérin. Caddy S; Yudin MH; Hakim J; Money DM J Obstet Gynaecol Can; 2016 Dec; 38(12S):S407-S417. PubMed ID: 28063552 [No Abstract] [Full Text] [Related]
19. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. van Schalkwyk J; Yudin MH; J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874 [TBL] [Abstract][Full Text] [Related]
20. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection? Guderian AM; Trobough GE Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]